The Asia-Pacific Antifungal Drugs Market is estimated at
$1.94 billion in 2016 and is poised to be growing at a CAGR of 4.1%, to reach
$2.38 billion by 2021.
In the following few years, the market is projected to
grow enormously with the growing global population.
Browse market data tables and in-depth TOC of the Asia-Pacific
Antifungal Drugs Market to 2021 @ http://www.marketdataforecast.com/market-reports/asia-pacific-anti-fungal-drugs-market-247/
Antifungal drugs are used to cure fungal infections which
are usually caused by unclean, unhygienic and damp environment. Fungal infections
are the invasion of epithelial tissue by microscopic organisms. Systemic fungal
infections are caused by the indigestion or inhalation of fungus spores and
cause fungal pneumonia and opportunistic fungus causes diseases like
candidaisis, meningitis, mucormycosis, etc. Most of the fungal infections and
fungal diseases are generally non-lethal but they are very uncomfortable to
live with. Commonly occurring fungal infections are responsible for the rise of
antifungal drugs market. Antifungal drugs work through various mechanisms such
as by inhibiting cell wall formation, cell membrane disruption and cell
division.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/asia-pacific-anti-fungal-drugs-market-247/request-sample
The major factors driving the market are rising awareness of
fungal infections with the increasing incidence of antifungal infections all
over the world, rising government and corporate funding in the industry.
Further, more and more development of public private partnership in the
pharmaceutical industry and the rising popularity of over-the-counter
antifungal drugs for dermal infections is vastly responsible for the increasing
the market size. Also, the increase of population with weak, in whom the
occurrence of fungal infections is much more than average, will drive the
market. Existing high penetration of conventional drugs used for the treatment
of fungal infections is restraining the Asia-Pacific Antifungal drugs market’s
growth.
Inquire before buying @ http://www.marketdataforecast.com/market-reports/asia-pacific-anti-fungal-drugs-market-247/inquire
The key challenges faced by the Asia-Pacific Antifungal
drugs market are cost of drugs and their effectiveness in treatments. As many
countries in Asia-Pacific are having emerging economies, the antifungal drugs
market in the region is going to grow fastest.
Avail discount @ http://www.marketdataforecast.com/market-reports/asia-pacific-anti-fungal-drugs-market-247/request-discount
The antifungal drugs market is segmented by drug type into
Echinocandins, Azoles, Polyenes, Allylamines and Other Drugs. Also, the market
is segmented by type of therapeutic indications into Aspergillosis,
Dermatophytosis, Candidiasis, Other therapeutic indications. And the market is
also segmented by applications into Powders, Ointments, Drugs, Pastes. While
Azoles which include fluconazole, itraconazole, ketoconazole, posaconazole and
voriconazole, are systemically acting, Echinocandins which include
anidulafungin, caspofungin and micafungin are lipopeptides derived from natural
fungal fermentation products and Polyenes which include include amphotericin B
deoxycholate and liposomal amphotericin B. Corifungin are systemically acting
and disrupts eukaryotic cellular membranes. Azoles segment is the largest
segment of the market followed by echinocandins.
On the basis of geography, the Asia-pacific antifungal drugs
market is segmented into the countries China, India, Japan, South Korea. The
Antifungal drugs market in Asia-Pacific is the fastest growing followed by
Latin America. India antifungal drugs market is the fastest growing in the
Asia-pacific region.
Major market players dominating the market, include
Alternaria, Pfizer, Novartis, Sanofi-Aventis, Merck & Co., Asperqillus,
Bayer Healthcare, Kramer Laboratories, Enzon Pharmaceuticals, Glaxosmithkline
Gilead and Abbott Laboratories.
About Us:
Market Data Forecast is a firm working in the area of market
research and business intelligence. With rich experience in research across
various business domains, we cater to the needs of both individual and
corporate clients. Our analyst team comprises expert professionals in market
research, who with their collective knowledge and sksillset dedicatedly serve
clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
No comments:
Post a Comment